Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302012 · ClinicalTrials.gov registry record
Assessment of EyeArt Performance With Retinal Imaging Devices
A clinical trial, sponsored by Eyenuk.
- Completed
- Registry status
- 62
- Enrollment target
NCT04302012: Completed study, sponsored by Eyenuk.
NCT04302012 is a clinical trial that has completed, run by Eyenuk. The registered enrollment target is 62 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04302012 has completed, sponsored by Eyenuk.
- COMPLETED
- Registry status
- 62 participants
- Enrollment target
Study Summary
The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using multiple retinal imaging devices and operators.
Interventions
- PROCEDURE Color fundus photography
- DRUG Mydriatic Agent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-12-18 |
| Est. Completion | 2020-02-27 |
What the finished NCT04302012 record still lists
NCT04302012 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 62 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Color fundus photography is the first listed.
NCT04302012 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04302012 about?
NCT04302012 is a clinical study titled "Assessment of EyeArt Performance With Retinal Imaging Devices". The study evaluates the performance of the EyeArt system for detecting diabetic retinopathy from images captured using multiple retinal imaging devices and operators.
What is the current status of trial NCT04302012?
This trial is currently completed. The enrollment target is 62 participants. The study started on 2019-12-18. Estimated completion is 2020-02-27.
What interventions are being tested in trial NCT04302012?
The interventions under investigation include: Color fundus photography (PROCEDURE), Mydriatic Agent (DRUG).
Who is sponsoring clinical trial NCT04302012?
This trial is sponsored by Eyenuk, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI